Peptide Therapy Cost: A Transparent Breakdown (No Surprises)

Why Peptide Therapy Pricing Is All Over the Map

Scroll through any longevity forum or biohacking subreddit and you'll find two wildly different things sitting side by side: someone who says they're paying $80 a month for peptide therapy, and someone else who swears they're shelling out $800. Both of them could be right. Peptide therapy pricing is genuinely chaotic, and not in a "the market will sort it out" way. It's chaotic because the term "peptide therapy" covers an enormous range of compounds, delivery methods, clinical models, and regulatory environments that all pull costs in different directions.

If you're trying to figure out what peptide therapy actually costs, and whether any of it is worth your money, this breakdown is for you. No fluff, no upselling, just a real look at what drives the numbers and how to tell whether you're getting a good deal or getting fleeced.

The short answer: peptide therapy typically costs anywhere from $75 to $600 per month, depending on the peptide, delivery method, clinic model, and whether you're buying it legally through a physician or chasing it through grey-market sources. Let's break down why.

What Is Peptide Therapy, Really?

Before we get into dollars, a quick grounding. Peptides are short chains of amino acids — think of them as the body's cellular text messages. Where a full protein like insulin is a long, complex molecule, a peptide is a shorter, more targeted signal. Your body already makes thousands of them. What peptide therapy does is introduce specific synthetic versions to nudge biological processes in a desired direction.

The category is wide. Some peptides (like the GLP-1 class) are FDA-approved drugs prescribed for weight management and metabolic health. Others are compounded by licensed pharmacies and prescribed off-label. And some exist in a murkier regulatory space that has gotten considerably more complicated in recent years. Where your peptide sits on that spectrum matters enormously for both cost and safety.

There's no single "peptide therapy." That's the first thing to internalize when you're trying to understand pricing. You're really asking about the cost of several distinct clinical services that happen to share a category name.

Peptide Therapy Cost by Peptide Type

Different peptides occupy completely different price tiers. Here's an honest breakdown of what you can expect for the most commonly discussed categories:

GLP-1 Receptor Agonists (Semaglutide, Tirzepatide)

These are the most talked-about peptides right now. FDA-approved brand names like Wegovy and Zepbound carry list prices of $900 to $1,400 per month without insurance. With insurance coverage for obesity, that can drop to near zero, but coverage is inconsistent and frequently denied.

Compounded versions from 503B outsourcing facilities can run $200 to $500 per month depending on dose and provider. The FDA has been tightening compounding rules here, so availability and pricing are shifting in real time. If you're seeing offers below $150/month for semaglutide, read the fine print very carefully. Some of those are for peptide analogs (like semaglutide "acetate") that are not the same compound as the approved drug.

Growth Hormone Secretagogues (Sermorelin, Ipamorelin, CJC-1295)

These peptides stimulate your pituitary gland to produce more of its own growth hormone rather than injecting growth hormone directly. They're typically compounded and range from $150 to $400 per month. The cost depends heavily on whether it's a single peptide or a stack (like Ipamorelin/CJC-1295 combined), and on the compounding pharmacy your provider uses.

Here's the catch: in 2023, the FDA placed sermorelin and several related growth hormone secretagogues on a list that restricts their compounding for certain formulations. The landscape has shifted. A clinic charging you for these compounds should be able to explain exactly what they're sourcing and from where.

BPC-157 and TB-500 (Tissue Repair Peptides)

BPC-157 is probably the peptide the biohacking crowd talks about most. Originally studied for gut healing and tissue repair, it's been used widely for joint and muscle recovery. TB-500 (a fragment of thymosin beta-4) is often stacked with it for similar goals. These typically cost $75 to $200 per month when sourced from a compounding pharmacy through a legitimate prescription.

These compounds are also widely available from "research chemical" suppliers at significantly lower prices, sometimes under $50. We'll address why that cost comparison isn't really apples-to-apples in a moment.

Oxytocin

Often called the "bonding hormone," oxytocin is compounded as a nasal spray or troche (a dissolving lozenge) for uses ranging from social anxiety to libido to stress response. Compounded oxytocin typically runs $50 to $150 per month, making it one of the more accessible prescription peptide options. The clinical supervision required to use it appropriately still matters, though, even at this price point.

Healthspan offers both Oxytocin Nasal Spray and Oxytocin Troche through its supervised protocol, which includes a clinical consultation to determine whether oxytocin is actually the right fit for your situation.

Peptide Stacks and Custom Protocols

Many clinics combine multiple peptides into a protocol targeting a specific goal, like body recomposition, cognitive performance, or longevity. These stacks range widely, from $300 to over $1,000 per month, depending on what's included. This is where pricing gets hardest to evaluate without understanding exactly what you're paying for.

Peptide Therapy Cost by Delivery Method

The same peptide in a different form can cost significantly more or less. Here's why delivery method affects your bill:

• Subcutaneous injection: Most bioavailable for most peptides. Requires syringes, alcohol swabs, and some training. Often the most cost-effective delivery per unit of active compound, but has higher upfront friction.
• Nasal spray: More convenient, good bioavailability for some compounds (oxytocin is a classic example). Compounding nasal sprays is a more involved process, so the per-dose cost is often slightly higher than injectable.
• Oral (troches, capsules): Convenient, but most peptides are degraded by stomach acid before they reach systemic circulation. Troches (dissolved under the tongue) bypass some of that. True oral bioavailability for most peptides is low, which means higher doses are required, which often means higher cost.
• Topical: For specific applications like skin repair, topical peptide creams are increasingly popular. Bioavailability is localized, which is fine for the intended purpose but doesn't translate to systemic effects.

The general rule: injectable is cheapest per effective dose, oral is most convenient but often least efficient, and nasal sits somewhere in between depending on the compound.

What the Clinic Model Does to Pricing

This is the part most cost breakdowns skip, and it's arguably the most important variable. Who prescribes and monitors your peptide therapy determines a significant chunk of what you pay, and also determines how safe and effective the whole thing actually is.

Direct-to-Consumer Telehealth

The most cost-efficient model for the patient, when done well. You have an online consultation with a licensed clinician, labs are ordered to establish baseline and screen for contraindications, and medication is shipped from a licensed compounding pharmacy. Monthly costs typically include the medication plus an ongoing care fee. Well-run DTC telehealth for peptide therapy ranges from $100 to $500/month all-in, depending on the protocol.

Med Spa or Wellness Clinic

In-person, often expensive, and highly variable in clinical rigor. You might be seeing a physician, a PA, or sometimes a nurse under loose physician oversight. Markup on compounded medications can be substantial. In-person consultations add cost. You can easily pay $400 to $1,200/month at a premium med spa for the same compounds you'd access at half the price through a well-supervised telehealth practice. You're paying for the ambiance more than the clinical value.

"Research Chemical" Suppliers (Not a Clinic)

You can buy peptides labeled "for research use only, not for human consumption" from online suppliers at a fraction of prescription prices. Some people do this. The risks are real: no quality assurance, no dosing guidance, no monitoring, and the FDA has been increasingly active in this space. A peptide from a research supplier may contain the right compound at the right dose, or it may not. There's no way to know without independent testing. This is the $40 option that comes with a different kind of cost.

The Real Cost of Peptide Therapy: What You're Actually Paying For

Here's the thing most pricing discussions miss: the compound itself is often the smallest part of what you're buying. Or at least, it should be.

When you access peptide therapy through a legitimate clinical protocol, you're paying for:

• Physician consultation: Someone who takes your history, reviews your labs, identifies contraindications, and determines whether this peptide is actually indicated for you
• Lab testing: Baseline bloodwork to establish where you're starting, and follow-up labs to confirm the protocol is working and not causing harm
• Pharmacy quality assurance: Compounds from licensed 503A compounding pharmacies are subject to state pharmacy board oversight and USP standards
• Ongoing monitoring and dose adjustment: Your needs change. A good clinical model checks in, adjusts doses, and catches problems before they become serious
• Medical accountability: Someone's license is on the line if this goes wrong

When you strip all of that out to get the cheapest possible price, you're not getting peptide therapy. You're getting a compound with no clinical context around it. That's a fundamentally different thing.

The Reality Check: What We Don't Know About Peptides

Let's be honest here. Peptide therapy is a broad category that includes some well-studied compounds (GLP-1 agonists have extensive clinical trial data) and some that are riding significantly more on animal research and mechanistic reasoning than on robust human trials.

BPC-157 has impressive preclinical data in rodents. The human data is much thinner. You are not a rat. The tissue repair effects that show up clearly in mouse models don't always translate cleanly to humans, and we don't have the long-term safety data for many of these compounds that we'd want before declaring them confidently effective.

Growth hormone secretagogues are better studied but still lack the kind of large, long-term randomized controlled trials that you'd want for something you're taking for years. GLP-1s are the exception, not the rule, in terms of clinical evidence quality.

This doesn't mean peptide therapy is bunk. It means you should price it accordingly. A protocol built on emerging evidence is worth exploring with appropriate clinical oversight. It's not worth spending $1,200 a month on at a med spa with minimal monitoring, based on before-and-after photos on Instagram.

Who Is Peptide Therapy Actually Right For?

If you're considering peptide therapy for cost-effectiveness, you'll get the most value if you fit one or more of these profiles:

• You're between 35 and 65, have your baseline labs done, and have a specific, measurable goal (body composition, metabolic health, recovery, hormonal support)
• You've already addressed the fundamentals: sleep, resistance training, nutrition, and stress management. Peptides as a foundation don't make sense. Peptides on top of a solid foundation can make a real difference.
• You're interested in GLP-1 therapy for weight management or metabolic health and want a clinically supervised protocol rather than a subscription box
• You want to explore oxytocin for stress, social connection, or libido and want it done with actual clinical oversight
• You've done the research, understand the evidence base, and want a physician who will engage with you seriously rather than either dismiss the idea or just take your money

If you're looking for a quick fix, or you want the cheapest possible option regardless of supervision, peptide therapy probably won't deliver what you're hoping for.

Risks and Side Effects: What to Know

This varies significantly by peptide, but common considerations include:

• GLP-1 agonists: Nausea, vomiting, and GI discomfort are common, especially early. Rare but serious risks include pancreatitis and, based on animal studies (not confirmed in humans), thyroid C-cell changes. Dose titration matters a lot here.
• Growth hormone secretagogues: Water retention, increased appetite, fatigue, and joint discomfort at higher doses. People with active malignancy should avoid them, given GH's role in cell proliferation.
• BPC-157: Generally well-tolerated in the limited human data available. Main concern is the lack of long-term safety data.
• Oxytocin: Generally very well tolerated at compounded doses. Can affect mood and social behavior in ways that aren't always predictable; clinical oversight helps manage this.

The risk profile of any peptide changes meaningfully depending on your individual health status. This is exactly why clinical supervision isn't optional — it's the thing that makes the risk-benefit calculation actually calculable.

How to Get Started With Peptide Therapy Through Healthspan

If you've read this far and you're thinking "I want to do this right," Healthspan's approach is built for exactly that. Rather than selling you a specific peptide protocol before knowing anything about you, Healthspan starts where it should: with your baseline data.

The Longevity Optimization program is a good starting point if you're looking at peptide therapy as part of a broader longevity protocol. It includes comprehensive lab work to establish your baseline, a clinical consultation with a physician who specializes in longevity medicine, and an individualized protocol review that covers which interventions are appropriate for your specific picture.

For those specifically interested in GLP-1 therapy, Healthspan offers GLP-1 Longevity Care, which includes ongoing clinical monitoring, dose adjustment, and support throughout the protocol — not just an initial prescription with no follow-up.

If oxytocin is on your radar, both the Oxytocin Nasal Spray and Oxytocin Troche are available through supervised protocols that include a consultation to confirm it's the right fit.

The difference between Healthspan and a grey-market peptide vendor isn't just price — it's the clinical layer that makes the whole thing worth doing. Start by booking a consultation, getting your labs done, and having a real conversation with a clinician about what your goals are and what the evidence actually supports.

Frequently Asked Questions About Peptide Therapy Cost

How much does peptide therapy cost per month?

Peptide therapy typically costs between $75 and $600 per month, depending on the peptide, delivery method, and whether you're going through a supervised clinical provider or an online pharmacy. GLP-1s like semaglutide run higher (often $200 to $500/month for compounded versions), while compounds like oxytocin or BPC-157 can be under $200/month through a legitimate compounding pharmacy.

Is peptide therapy covered by insurance?

Rarely. FDA-approved GLP-1 drugs like Wegovy may be covered by some insurance plans for qualifying diagnoses, but coverage is inconsistent and often denied. Most other peptide therapies are compounded medications prescribed off-label, which insurance does not typically cover. You should plan to pay out of pocket for most peptide protocols.

Why is there such a big price difference between peptide providers?

Price differences reflect differences in what's included: physician consultations, lab work, pharmacy quality, and ongoing monitoring all add cost but also add safety and effectiveness. Cheaper options often skip clinical oversight or source compounds from unregulated suppliers. Paying more doesn't guarantee quality, but unusually low prices are a meaningful red flag.

How do I know if I'm paying for quality peptide therapy?

A quality peptide therapy protocol should include at minimum: a consultation with a licensed prescriber, baseline lab testing, a prescription sent to a licensed compounding pharmacy (503A or 503B), and a follow-up mechanism for monitoring and dose adjustment. If any of those elements are missing, you're not really getting clinical peptide therapy — you're getting a compound with no medical context around it.

Are cheaper research peptides the same as prescription peptides?

No. Research-grade peptides sold online for "non-human use" are not subject to the quality controls of licensed compounding pharmacies. They may be the correct compound, underdosed, overdosed, contaminated, or mislabeled. There's no regulatory oversight and no way to verify what you're actually getting without independent lab testing. The price difference reflects that absence of accountability.

What's the cheapest legitimate way to access peptide therapy?

Telehealth-based peptide therapy from a licensed clinician is typically the most cost-efficient legitimate route. Prices are generally lower than in-person med spas because there's less overhead, and the clinical quality can be just as high or higher. For common compounds like oxytocin or compounded GLP-1 peptides, expect to pay $100 to $400/month all-in through a quality telehealth provider.

Do peptides actually work, or is this mostly hype?

It depends entirely on the peptide. GLP-1 agonists have robust human clinical trial data and are among the most well-evidenced metabolic interventions available. Growth hormone secretagogues have a reasonable evidence base for body composition and recovery. BPC-157 has impressive animal data but limited human trials. The category ranges from well-proven to promising-but-unconfirmed. Blanket enthusiasm and blanket skepticism are both wrong.